HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E.P.T. Pregnancy Test Will Get Marketing Bump From NFI Consumer

This article was originally published in The Pink Sheet

Executive Summary

NFI Consumer Healthcare purchases the e.p.t. pregnancy kit brand from Prestige Brands Holdings with plans to expand the line’s footprint and marketing support. The spin-off is Prestige Brands’ latest toward focusing on core brands in its portfolio.

You may also be interested in...



Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform

Prestige Brands makes the deal three weeks after divesting the slower-selling Massengill douche brand and as it makes a top marketing priority of growing sales of its Monistat yeast treatment line.

Moberg Adds DermoPlast Line With Bondholders' Blessing For More

Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.

Moberg Sustains Derma Drive, Acquires Prestige Brands' New Skin

The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122848

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel